BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort

* HIGHMARK INC. SIGNS OUTCOMES-BASED AGREEMENT WITH ASTRAZENECA FOR SYMBICORT Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.